Who we are

Polpharma is the largest Polish manufacturer of drug products and active pharmaceutical ingredients. We specialize in manufacturing cardiological, gastrological and neurological drugs, which are prescribed and administered in inpatient healthcare. We also manufacture a wide range of OTC drugs.

A milestone in the company’s history was its privatization in 2000, based solely in the Polish capital. Its privatization gave the green light for thorough changes, which turned Polpharma into a strong and modern company, and a leader on the Polish pharmaceutical market. Polpharma, together with Medana Pharma, wherein Polpharma is a majority shareholder, is the Polish market leader by volume of drug packages sold. At the same time, the company is reinforcing its position throughout international markets. It has its own representative offices in Russia, Lithuania, Ukraine, Kazakhstan, Belarus, Vietnam, Azerbaijan and Uzbekistan.

Polpharma combines tradition and experience with modern technologies and the highest manufacturing standards. We constantly increase the effectiveness of our operations and use the elaborated benefits for further intensive development. Development is reflected, among others, in the company’s investments. Since 2000, Polpharma has invested approximately 700 m PLN.

Polpharma's  greatest asset is its experienced and highly skilled staff. Approximately 2,600 people work at the Pharmaceutical Works in Starogard Gdański, in the Trade Office in Warsaw its branches in foreign markets for the company’s success.